Nibras E El Sherif1, Nathaniel W Taggart2. 1. Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. 2. Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. taggart.nathaniel@mayo.edu.
Abstract
PURPOSE OF REVIEW: To review the use of covered stents in the treatment of coarctation of the aorta (CoA) and right ventricle to pulmonary artery (RV-PA) conduit obstruction. RECENT FINDINGS: The only commercially available covered stent approved for treatment of CoA and dysfunctional RV-PA conduits is the covered Cheatham-Platinum stent (CCPS). Early outcomes have demonstrated its safety and have suggested its efficacy in treating or preventing aortic wall injury (AWI) or conduit disruption. A recent study of CCPS use for CoA reported a progressive risk of stent fracture over time and a risk of AWI despite the purported protection that the CCPS provides. The use of other covered stents has been reported, but large, systematic studies are lacking. CCPS use may reduce but does not eliminate the risk of conduit disruption or AWI. Structural limitations of the CCPS may predispose it to stent fracture. Access to a broad range of covered stents continues to be an unmet need in the field of congenital interventional cardiology.
PURPOSE OF REVIEW: To review the use of covered stents in the treatment of coarctation of the aorta (CoA) and right ventricle to pulmonary artery (RV-PA) conduit obstruction. RECENT FINDINGS: The only commercially available covered stent approved for treatment of CoA and dysfunctional RV-PA conduits is the covered Cheatham-Platinum stent (CCPS). Early outcomes have demonstrated its safety and have suggested its efficacy in treating or preventing aortic wall injury (AWI) or conduit disruption. A recent study of CCPS use for CoA reported a progressive risk of stent fracture over time and a risk of AWI despite the purported protection that the CCPS provides. The use of other covered stents has been reported, but large, systematic studies are lacking. CCPS use may reduce but does not eliminate the risk of conduit disruption or AWI. Structural limitations of the CCPS may predispose it to stent fracture. Access to a broad range of covered stents continues to be an unmet need in the field of congenital interventional cardiology.
Authors: Benjamin Blais; Karen Carr; Sanjay P Sinha; Morris M Salem; Daniel S Levi Journal: Catheter Cardiovasc Interv Date: 2020-12-07 Impact factor: 2.692
Authors: Ram N Bishnoi; Thomas K Jones; Jacqueline Kreutzer; Richard E Ringel Journal: Catheter Cardiovasc Interv Date: 2014-10-07 Impact factor: 2.692
Authors: Kevin D Hill; Bryan H Goldstein; Michael J Angtuaco; Patricia Y Chu; Gregory A Fleming Journal: Cardiol Young Date: 2016-11-10 Impact factor: 1.093
Authors: Nathaniel W Taggart; Matthew Minahan; Allison K Cabalka; Frank Cetta; Kudret Usmani; Richard E Ringel Journal: JACC Cardiovasc Interv Date: 2016-02-17 Impact factor: 11.195
Authors: Aphrodite Tzifa; Peter Ewert; Grazyna Brzezinska-Rajszys; Bjoern Peters; Maria Zubrzycka; Eric Rosenthal; Felix Berger; Shakeel A Qureshi Journal: J Am Coll Cardiol Date: 2006-03-20 Impact factor: 24.094